OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Ana Pereira

3 Projects | 1 Researchers | $406,000 Invested

2017

Icahn School of Medicine at Mount Sinai

Ana Pereira, MD

Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment - Expansion to an additional clinical site

  • Funding Amount: $106,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

The Rockefeller University

Ana Pereira, MD

Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment (follow-on funding)

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2012

The Rockefeller University

Ana Pereira, MD

Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed